BioCryst Pharmaceuticals Inc (BCRX)
7.05
-0.30
(-4.02%)
USD |
NASDAQ |
Nov 05, 16:00
7.06
+0.01
(+0.14%)
After-Hours: 18:51
BioCryst Pharmaceuticals Free Cash Flow: -85.80M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -85.80M |
| March 31, 2024 | -103.56M |
| December 31, 2023 | -97.31M |
| September 30, 2023 | -112.21M |
| June 30, 2023 | -123.95M |
| March 31, 2023 | -132.67M |
| December 31, 2022 | -163.20M |
| September 30, 2022 | -172.39M |
| June 30, 2022 | -163.42M |
| March 31, 2022 | -161.64M |
| December 31, 2021 | -144.54M |
| September 30, 2021 | -153.66M |
| June 30, 2021 | -168.45M |
| March 31, 2021 | -173.34M |
| December 31, 2020 | -135.62M |
| September 30, 2020 | -103.46M |
| June 30, 2020 | -92.76M |
| March 31, 2020 | -86.23M |
| December 31, 2019 | -89.93M |
| September 30, 2019 | -103.49M |
| June 30, 2019 | -110.84M |
| March 31, 2019 | -100.33M |
| December 31, 2018 | -92.93M |
| September 30, 2018 | -79.48M |
| June 30, 2018 | -57.02M |
| Date | Value |
|---|---|
| March 31, 2018 | -52.63M |
| December 31, 2017 | -41.47M |
| September 30, 2017 | -36.69M |
| June 30, 2017 | -41.81M |
| March 31, 2017 | -45.14M |
| December 31, 2016 | -58.72M |
| September 30, 2016 | -71.74M |
| June 30, 2016 | -66.80M |
| March 31, 2016 | -36.05M |
| December 31, 2015 | -18.24M |
| September 30, 2015 | -13.32M |
| June 30, 2015 | -9.151M |
| March 31, 2015 | -33.98M |
| December 31, 2014 | -38.66M |
| September 30, 2014 | -29.22M |
| June 30, 2014 | -28.51M |
| March 31, 2014 | -24.33M |
| December 31, 2013 | -26.56M |
| September 30, 2013 | -29.07M |
| June 30, 2013 | -32.93M |
| March 31, 2013 | -36.39M |
| December 31, 2012 | -37.51M |
| September 30, 2012 | -34.47M |
| June 30, 2012 | -33.15M |
| March 31, 2012 | -30.27M |
Free Cash Flow Range, Past 5 Years
-173.34M
Minimum
Mar 2021
-85.80M
Maximum
Jun 2024
-129.69M
Average
-132.67M
Median
Mar 2023
Free Cash Flow Benchmarks
| Novavax Inc | -23.57M |
| AIM ImmunoTech Inc | -23.91M |
| Perspective Therapeutics Inc | -24.58M |
| Protalix BioTherapeutics Inc | -4.182M |
| Armata Pharmaceuticals Inc | -46.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.368M |
| Cash from Investing (Quarterly) | -2.449M |
| Cash from Financing (Quarterly) | -1.966M |
| Free Cash Flow Per Share (Quarterly) | -0.0074 |
| Free Cash Flow to Equity (Quarterly) | 3.032M |
| Free Cash Flow to Firm (Quarterly) | 19.95M |
| Free Cash Flow Yield | -6.06% |